2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1861495384 M.D.
Verify on CMS →

JOHN LONG, M.D.

Ophthalmic Plastic and Reconstructive Surgery Physician in BIRMINGHAM, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
738
Medicare Part D claims · 386 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$325.52
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOHN LONG, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 738 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
738
Part D claims, 2023
76%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN LONG, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JOHN LONG, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN LONG, M.D.?

Below national average

NPI registry status

Active

Issued 05/30/2005

NPI 1861495384

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

738 18% vs specialty avg

2023 prescription claims

Specialty avg: 624

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Alabama

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Alabama providers

Alabama providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within Alabama

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within Alabama

Medicare quality performance — MIPS

JOHN LONG, M.D.'s 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN LONG, M.D. is a Ophthalmic Plastic and Reconstructive Surgery Physician provider practicing in BIRMINGHAM, Alabama, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1861495384. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JOHN LONG, M.D. appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding M.D. credentials at 1000 19TH ST S, BIRMINGHAM, AL, 35205, with a listed phone of (205) 930-0700. NPI 1861495384 was issued on 05/30/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LONG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 738 prescription claims written by this provider, covering 386 Medicare beneficiaries and totaling roughly $385K in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 26.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1000 19TH ST S
BIRMINGHAM, AL 35205

Provider Details

NPI 1861495384
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 05/30/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where JOHN LONG, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALABAMA OPHTHALMOLOGY ASSOCIATES, P.C.
BIRMINGHAM, AL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOHN LONG, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$326

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

JOHN LONG, M.D. — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 738 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

738
Total Claims
$385K
Total Drug Cost
386
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
771
Total Day Supply
9,839
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$380K
Generic Drug Cost
$5K
Opioid Claims
194 (26.3% rate)
Antibiotic Claims
98

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.15
Gender Split
57% female / 43% male
Age Distribution
<65: 37, 65-74: 182, 75-84: 134, 85+: 33

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
279
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
188
Prednisolone Acetate
68
Ciprofloxacin Hcl
47
Doxycycline Hyclate
28
Diazepam
21
Erythromycin
Erythromycin Base
13
Clonazepam
12
Methylprednisolone
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How JOHN LONG, M.D. fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

JOHN LONG, M.D.'s 738 claims are above the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as LONG.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN LONG, M.D.'s specialty?
JOHN LONG, M.D. specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in BIRMINGHAM, Alabama. Credentials: M.D..
How much does JOHN LONG, M.D. prescribe under Medicare Part D?
In 2023, JOHN LONG, M.D. wrote 738 Medicare Part D claims totaling $385K in drug costs for 386 beneficiaries.
What is JOHN LONG, M.D.'s Medicare quality score?
JOHN LONG, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOHN LONG, M.D. located?
JOHN LONG, M.D. is located at 1000 19TH ST S, BIRMINGHAM, AL, 35205. Phone: (205) 930-0700.
What is JOHN LONG, M.D.'s NPI number?
JOHN LONG, M.D.'s National Provider Identifier (NPI) is 1861495384, issued on 05/30/2005.
Does JOHN LONG, M.D. prescribe more brand-name or generic drugs?
JOHN LONG, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $380K in brand drug costs.
Does JOHN LONG, M.D. prescribe opioids?
Yes, JOHN LONG, M.D. had 194 opioid claims in 2023 with an opioid prescribing rate of 26.3%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does JOHN LONG, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN LONG, M.D.'s most frequently prescribed drugs include Neomycin-Polymyxin-Dexameth, Hydrocodone-Acetaminophen, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN LONG, M.D. accept Medicare?
JOHN LONG, M.D. appears in CMS Medicare data with 738 Part D claims and 386 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN LONG, M.D.'s credentials?
JOHN LONG, M.D.'s NPI is 1861495384 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology